About Byungchan Kim
Form D filings for NeuroLambda Therapeutics in 2024 list Byungchan Kim as director.
Byungchan Kim first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Byungchan Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Byungchan Kim works with at each company, as listed on that company's latest Form D.
NeuroLambda Therapeutics, Inc. · Form D, Jul 17, 2024
XJ
Xiaowei Jin
Director
SM
Sayan Mondal
President and director